Response: Do Nutritional and Inflammatory Indices Predict Response in Geriatric Gastric Cancer Patients Treated With Neoadjuvant FLOT Regimen?

QR Code

Response: Do Nutritional and Inflammatory Indices Predict Response in Geriatric Gastric Cancer Patients Treated With Neoadjuvant FLOT Regimen?

Saved in:

Bibliographic Details
Main Authors:	Yonca Yılmaz Ürün MD, Muslih Ürün MD
Format:	Article
Language:	English
Published:	SAGE Publishing 2025-06-01
Series:	Cancer Control
Online Access:	https://doi.org/10.1177/10732748251357472
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Letter to the Editor: Do Nutritional and Inflammatory Indices Predict Response in Geriatric Gastric Cancer Patients Treated With Neoadjuvant FLOT Regimen?
by: Aybala Nur Ucgul MD
Published: (2025-06-01)

Comparison of Neoadjuvant Chemotherapy With FLOT and Modified DCF Regimens in Nonmetastatic Gastric Adenocarcinoma
by: Mehdi Pourghasemian, et al.
Published: (2025-06-01)

Vitamin D Deficiency and Supplementation in Irritable Bowel Syndrome: Retrospective Evaluation of Subtype and Sex-Based Differences
by: Nur Düzen Oflas, et al.
Published: (2025-07-01)

Clinical case of pathological complete response of gastric cancer after one cycle of neoadjuvant chemotherapy with fot regimen
by: V. Yu. Skoropad, et al.
Published: (2023-01-01)

Assessment of the safety and feasibility of neoadjuvant chemotherapy (2 cycles of FLOT chemotherapy + chemoradiotherapy) followed by surgery in the treatment of locally advanced gastric cancer
by: D. Yu. Mironova, et al.
Published: (2024-03-01)

PATHOLOGICAL COMPLETE RESPONSE TO NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED GASTRIC CANCER
by: V. Yu. Skoropad, et al.
Published: (2020-07-01)

PATHOLOGICAL RESPONSE OF GASTRIC CANCER TO NEOADJUVANT PROLONGED CHEMORADIOTHERAPY FOLLOWED BY D2 GASTRECTOMY
by: Е. F. Lushnikov, et al.
Published: (2016-02-01)

Case Report: Pathological complete response achieved with neoadjuvant immunochemotherapy in synchronous multiple gastric adenocarcinoma
by: Ya-hui Sun, et al.
Published: (2025-07-01)

A microRNA signature associated with pathological complete response to novel neoadjuvant therapy regimen in triple-negative breast cancer
by: Raúl García-Vazquez, et al.
Published: (2017-05-01)

ASSESSMENT OF HISTOPATHOLOGICAL RESPONSE TO NEOADJUVANT CHEMORADIOTHERAPY IN GASTRIC CANCER PATIENTS: A MULTI-CENTER RANDOMIZED STUDY
by: V. Yu. Skoropad, et al.
Published: (2020-10-01)

Dissecting response to neoadjuvant immunotherapy-treated melanoma using cancer-immunity cycle-associated signatures
by: S. C. M. A. Wijnen, et al.
Published: (2025-06-01)

Gastric Ulcer Bleeding Caused by Systemic Inflammatory Response to Mycobacterial Bacteremia
by: Soo Bin Synn, et al.
Published: (2025-03-01)

Gastric Ulcer Bleeding Caused by Systemic Inflammatory Response to Mycobacterial Bacteremia
by: Soo Bin Synn, et al.
Published: (2024-12-01)

Neoadjuvant Treatment for Oesophago-Gastric Cancer
by: Anderson, John E., et al.
Published: (2012)

Impact of the immune cell population in peripheral blood on response and survival in patients receiving neoadjuvant chemotherapy for advanced gastric cancer
by: Qi He, et al.
Published: (2017-04-01)

Prognostic and Predictive Value of Pan-Immune Inflammation Value in Rectal Cancer Patients Treated With Neoadjuvant Therapy
by: Aybala Nur Ucgul MD, et al.
Published: (2025-07-01)

Response Assessment after Neoadjuvant Chemoradiotherapy in Rectal Cancer
by: Anuradha Chandramohan, et al.
Published: (2025-05-01)

Clinical and morphological response to neoadjuvant chemotherapy followed by chemoradiotherapy in a patient with locally advanced gastric cancer: a case report
by: V. Yu. Skoropad, et al.
Published: (2023-06-01)

COMPARATIVE ANALYSIS OF DIFFERENT NEOADJUVANT CHEMOTHERAPY REGIMENS FOR TRIPLE-NEGATIVE BREAST CANCER
by: P. V. Krivorotko, et al.
Published: (2017-12-01)

Clinical predictive factors associated with pathologic complete response in locally advanced rectal cancer
by: Yakup Bozkaya, et al.
Published: (2018-04-01)

Investigation of the Effects of Fingolimod on the LPS-Induced Inflammatory Response in the HUVEC Cell Line
by: Hamza Halıcı, et al.
Published: (2025-07-01)

Prognostic Significance of Inflammatory and Nutritional Biomarkers in Patients with Metastatic Gastric Cancer
by: Murad GULIYEV, et al.
Published: (2025-04-01)

Immune Cell Responses in Gastric Carcinoma
by: Ohtani, Haruo
Published: (2011)

Development and Validation of a New Immune-Inflammatory-Nutritional Score to Predict Pathological Complete Response in Triple-Negative Breast Cancer Undergoing Neoadjuvant Chemotherapy: A Two-Center Study
by: Wang S, et al.
Published: (2025-07-01)

Geriatric Nutritional Risk Index (GNRI) and Prognostic Nutritional Index (PNI) Before Treatment as the Predictive Indicators for Bone Metastasis in Prostate Cancer Patients
by: Chen L, et al.
Published: (2025-05-01)

A case of stage IV gastric cancer with para-aortic lymph node metastasis showing pathological complete response after neoadjuvant chemotherapy
by: Yuki Katsura, et al.
Published: (2020-01-01)

Promising Response to Neoadjuvant Chemotherapy Plus Immunotherapy in Metaplastic Breast Carcinoma
by: Tan Q, et al.
Published: (2025-05-01)

RETRACTED ARTICLE: Flot2 targeted by miR-449 acts as a prognostic biomarker in glioma
by: Shaosong Huang, et al.
Published: (2019-12-01)

Infections in patients with acute luekemia treated with different regimens
by: T. N. Aleksandrova, et al.
Published: (2025-05-01)

ASSESSMENT OF INFLAMMATORY RESPONSE INDICATORS AND PERIPHERAL HEMOPOIESIS AT NON-SPECIFIC ULCERATIVE COLITIS IN CHILDREN
by: V. V. Botvinyeva, et al.
Published: (2013-09-01)

STRESS-RESPONSE TO RADICAL SURGERIES FOR GASTRIC CANCER
by: S. V. Avdeev, et al.
Published: (2017-12-01)

MOLECULAR GENETIC MARKERS AS PREDICTORS OF TUMOR RESPONSE TO NEOADJUVANT CHEMOTHERAPY FOR RECTAL CANCER
by: S. R. Altybaev, et al.
Published: (2016-11-01)

MOLECULAR-GENETIC MARKERS OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY WITH ANTHRACYCLINES IN BREAST CANCER PATIENTS
by: P. V. Kazantseva, et al.
Published: (2016-07-01)

Pathological complete response following neoadjuvant chemotherapy for locally advanced intrahepatic cholangiocarcinoma
by: Yoshitaka Shimamaki, et al.
Published: (2024-02-01)

Application of N-NOSE for Evaluating the Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
by: Yoshihisa Tokumaru, et al.
Published: (2025-06-01)

Adaptive immune responses to SARS-CoV-2 in DMARD-treated patients with chronic inflammatory rheumatisms
by: Francis Berenbaum, et al.
Published: (2025-07-01)

Development and validation of nomogram for predicting pathological complete response to neoadjuvant chemotherapy and immunotherapy for locally advanced gastric cancer: a multicenter real-world study in China
by: Hao Cui, et al.
Published: (2025-07-01)

Predictive Value of Individual Gastric Secretion Indices and Their Constellations for Predicting the Response of Gastric Mucosal Parietal Cells to Pentagastrin Stimulation and Famotidine Blocking Effect in Patients with Gastric and Duodenal Ulcers
by: M. Pliatsko, et al.
Published: (2025-03-01)

Opportunities and limitations of CT - assessment of neoadjuvant chemoradiation therapy of gastric cancer
by: T. A. Agababyan, et al.
Published: (2019-12-01)

Neoadjuvant systemic therapy for patients with gastric cancer: Current concepts and outcomes
by: Fatih Selcukbiricik, et al.
Published: (2016-01-01)